TCR2 Therapeutics Inc.
TCRR
4
|
$1.48
3.38%
3.9M
|
Health Technology
(0.0% 1d) (0.0% 1m) (-14.9% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (906.93% volume)
Earnings Calendar: 2023-08-07
Market Cap: $ 58,107,383
http://www.tcr2.com
Sec Filling | Patents | 83 employees
(US) TCR2 Therapeutics, Inc. is an immunotherapy company, which develops biological drugs and engineering t-cells for cancer therapy. The firm offers cancer therapy, t-cell biology, immunology and molecular biology. It also engages in the research and collaboration with academic laboratories and industry partners in the field of t-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle in May 2015 and is headquartered in Cambridge, MA.
cancer immunotherapy immunology t-cell ceiling
add to watch list Paper trade email alert is off
Press-releases
T-cell Therapy Market Size to Grow USD US$ 76.6 billion from 2023-2033 | Says Transparency Market Research Inc.
Published: 2023-11-06 (Crawled : 15:00) - prnewswire.com
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.54%
H: 0.73%
C: 0.2%
t-cell research therapy market
CAR T-Cell Therapy Market size to grow at a CAGR of 13.44% from 2022 to 2027; Growing Awareness Regarding CAR T-cell Therapy to boost the market growth- Technavio.
Published: 2023-08-09 (Crawled : 08:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.92%
H: 0.0%
C: 0.0%
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.11%
H: 0.53%
C: 0.53%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.07%
H: 0.73%
C: 0.36%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 0.14%
H: 0.8%
C: 0.43%
GILD | $66.16 -1.15% -1.16% 6.4M
|
Health Technology
|
| O: 0.61%
H: 1.07%
C: -0.5%
AUTL | $4.8 -0.83% -0.83% 1.2M
|
Health Technology
|
| O: -2.02%
H: 3.44%
C: 2.75%
t-cell growing therapy market
Adaptimmune Announces Completion of Strategic Combination with TCR2 Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
Published: 2023-06-01 (Crawled : 22:00) - biospace.com/
ADAP | $0.8984 -8.98% -9.86% 3.3M
|
Health Technology
|
| O: 1.96%
H: 7.69%
C: 4.81%
cell tumor therapeutics therapy
TCR² Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-05-11 (Crawled : 11:00) - globenewswire.com
TCRR 4 | $1.48 3.38% 3.9M
|
Health Technology
|
| O: -1.99%
H: 0.0%
C: 0.0%
ADAP | $0.8984 -8.98% -9.86% 3.3M
|
Health Technology
|
| O: 0.71%
H: 0.0%
C: -3.55%
update therapeutics financial results
TCR² Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-05-08 (Crawled : 20:00) - globenewswire.com
TCRR 4 | $1.48 3.38% 3.9M
|
Health Technology
|
| O: 0.51%
H: 2.03%
C: 0.51%
nasdaq grants therapeutics
Global Pancreatic Cancer Competitive Landscape Report 2023: Comprehensive Insights about 250+ Companies and 300+ Drugs
Published: 2023-05-08 (Crawled : 15:00) - prnewswire.com
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.11%
H: 0.72%
C: 0.3%
TCRR 4 | $1.48 3.38% 3.9M
|
Health Technology
|
| O: 6.91%
H: 1.49%
C: -2.49%
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
|
| O: 0.03%
H: 0.17%
C: -1.19%
BNTX | $86.19 -0.24% -0.24% 580K
|
Health Technology
|
| O: 4.23%
H: 0.0%
C: -4.4%
ADAP | $0.8984 -8.98% -9.86% 3.3M
|
Health Technology
|
| O: 1.43%
H: 2.11%
C: -1.41%
companies report cancer pancreatic global
TCR² Therapeutics Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Update
Published: 2023-03-23 (Crawled : 11:00) - globenewswire.com
TCRR 4 | $1.48 3.38% 3.9M
|
Health Technology
|
| O: -1.94%
H: 0.0%
C: -6.58%
ADAP | $0.8984 -8.98% -9.86% 3.3M
|
Health Technology
|
| O: 0.9%
H: 1.79%
C: -2.68%
update therapeutics financial results
Moore Kuehn Encourages KBAL, DSEY, RADI, and TCRR Investors to Contact Law Firm
Published: 2023-03-10 (Crawled : 19:00) - prnewswire.com
ADAP | $0.8984 -8.98% -9.86% 3.3M
|
Health Technology
| Email alert
Add to watchlist
KBAL | $12.3 -0.89% -0.85% 0
|
Consumer Durables
| Email alert
Add to watchlist
RADI | $15.0 0.0% 9.5M
|
Finance
| Email alert
Add to watchlist
TCRR 4 | $1.48 3.38% 3.9M
|
Health Technology
| Email alert
Add to watchlist
HNI 4 | $41.26 0.44% 0.0% 170K
|
Producer Manufacturing
| Email alert
Add to watchlist
DSEY | $8.39 0.12% 1.7M
|
Manufacturing
| Email alert
Add to watchlist
INVESTIGATION ALERT: Halper Sadeh LLC Investigates RADI, ADAP, TCRR, ROCC
Published: 2023-03-07 (Crawled : 17:00) - prnewswire.com
ROCC 4 | $37.47 0.61% 5.7M
|
|
| O: -0.74%
H: 1.02%
C: -2.0%
BTE | $3.62 -0.11% 10M
|
Energy Minerals
|
| O: 0.0%
H: 0.25%
C: -3.45%
TCRR 4 | $1.48 3.38% 3.9M
|
Health Technology
|
| O: -3.09%
H: 17.83%
C: 1.91%
RADI | $15.0 0.0% 9.5M
|
Finance
|
| O: -0.07%
H: 0.45%
C: 0.21%
ADAP | $0.8984 -8.98% -9.86% 3.3M
|
Health Technology
|
| O: 0.0%
H: 3.45%
C: -5.3%
Adaptimmune and TCR² Therapeutics Announce Strategic Combination to Create a Preeminent Cell Therapy Company for Solid Tumors
Published: 2023-03-06 (Crawled : 12:00) - globenewswire.com
TCRR 4 | $1.48 3.38% 3.9M
|
Health Technology
|
| O: 30.25%
H: 14.84%
C: 4.52%
ADAP | $0.8984 -8.98% -9.86% 3.3M
|
Health Technology
|
| O: -23.3%
H: 10.37%
C: -2.22%
therapeutics tumors therapy
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
| 0001415889-24-003784 | 4 | 2024-02-14 | 2023-06-01 | Sell | J | 4394800 | 0 |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Last 48 Hours Insiders Buying
SNDA P 3000 | $29.61 3.35% 0.0% 30K
|
n/a
|
22:00
AXR P 2400 | $22.17 2.69% 0.0% 5.5K
|
Finance
|
21:00
FAST P 3350 | $67.5 -1.43% -1.45% 3.6M
|
Distribution Services
|
20:00
QCRH | $55.405 1.33% 1.31% 54K
|
Finance
|
18:01
RVP P 15363 | $1.05 0.96% 0.0% 120K
|
Health Technology
|
18:00
VUZI | $1.26 3.28% 3.17% 1M
|
Electronic Technology
|
18:00
TPL P 3 | $582.4 -0.44% 0.0% 63K
|
Miscellaneous
|
15:00
RELL | $10.15 2.94% 2.86% 94K
|
Electronic Technology
|
13:30
IZEA | $2.65 4.74% 4.53% 31K
|
Technology Services
|
00:00
RKT P 383 | $11.53 1.32% 0.0% 1.6M
|
Finance
|
22:30
CTRN P 18090 | $22.28 -0.4% -0.4% 55K
|
Retail Trade
|
22:00
BRN P 10650 | $2.8 0.36% -0.36% 54K
|
Energy Minerals
|
21:00
NEOG P 10000 | $11.94 -1.65% -1.68% 2.9M
|
Health Technology
|
16:30
RMCF | $3.61 2.27% 2.22% 18K
|
Consumer Non-Durables
|
20:10